AAAAAA

   
Results: 1-8 |
Results: 8
Antitumor activity of a human cytotoxic T-cell line (TALL-104) in brain tumor xenografts
Authors: Geoerger, B Tang, CB Cesano, A Visonneau, S Marwaha, S Judy, KD Sutton, LN Santoli, D Phillips, PC
Citation: B. Geoerger et al., Antitumor activity of a human cytotoxic T-cell line (TALL-104) in brain tumor xenografts, NEURO-ONCOL, 2(2), 2000, pp. 103-113
Phase I trial of TALL-104 cells in patients with refractory metastatic breast cancer
Authors: Visonneau, S Cesano, A Porter, DL Luger, SL Schuchter, L Kamoun, M Torosian, MH Duffy, K Sickles, C Stadtmauer, EA Santoli, D
Citation: S. Visonneau et al., Phase I trial of TALL-104 cells in patients with refractory metastatic breast cancer, CLIN CANC R, 6(5), 2000, pp. 1744-1754
Stabilization of disease as an indicator of clinical benefit associated with chemotherapy in non-small cell lung cancer patients
Authors: Cesano, A Lane, SR Ross, GA Fields, SZ
Citation: A. Cesano et al., Stabilization of disease as an indicator of clinical benefit associated with chemotherapy in non-small cell lung cancer patients, INT J ONCOL, 17(3), 2000, pp. 587-590
Adjuvant treatment of canine osteosarcoma with the human cytotoxic T-cell line TALL-104
Authors: Visonneau, S Cesano, A Jeglum, KA Santoli, D
Citation: S. Visonneau et al., Adjuvant treatment of canine osteosarcoma with the human cytotoxic T-cell line TALL-104, CLIN CANC R, 5(7), 1999, pp. 1868-1875
Adoptive therapy of canine metastatic mammary carcinoma with the human MHCnon-restricted cytotoxic T-cell line TALL-104
Authors: Visonneau, S Cesano, A Jeglum, KA Santoli, D
Citation: S. Visonneau et al., Adoptive therapy of canine metastatic mammary carcinoma with the human MHCnon-restricted cytotoxic T-cell line TALL-104, ONCOL REP, 6(6), 1999, pp. 1181-1188
Stabilization of disease as a useful predictor of survival following second-line chemotherapy in small cell lung cancer and ovarian cancer patients
Authors: Cesano, A Lane, SR Poulin, R Ross, G Fields, SZ
Citation: A. Cesano et al., Stabilization of disease as a useful predictor of survival following second-line chemotherapy in small cell lung cancer and ovarian cancer patients, INT J ONCOL, 15(6), 1999, pp. 1233-1238
Effects of development of host immunity on the biodistribution of xenogeneic MHC non-restricted cytotoxic T cells: Implications for adoptive cell therapy of cancer
Authors: Cesano, A Wortman, JA Pourdehnad, M Visonneau, S Mozley, D Bhatnagar, A Alavi, A Santoli, D
Citation: A. Cesano et al., Effects of development of host immunity on the biodistribution of xenogeneic MHC non-restricted cytotoxic T cells: Implications for adoptive cell therapy of cancer, INT J ONCOL, 14(2), 1999, pp. 233-244
Biodistribution of human MHC non-restricted TALL-104 killer cells in healthy and tumor bearing mice
Authors: Cesano, A Visonneau, S Tran, T Santoli, D
Citation: A. Cesano et al., Biodistribution of human MHC non-restricted TALL-104 killer cells in healthy and tumor bearing mice, INT J ONCOL, 14(2), 1999, pp. 245-251
Risultati: 1-8 |